Abeona therapeutics® announces option exercise by beacon therapeutics for novel aav204 capsid for ophthalmology gene therapy

Abeona will receive a license payment and potential development, regulatory, and sales milestones, and royalties abeona will receive a license payment and potential development, regulatory, and sales milestones, and royalties
ABEO Ratings Summary
ABEO Quant Ranking